Silica Particle Size Guide: How D50, Mesh and Microns Affect Performance

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: Novoray: Company Overview, Spherical Silica Products and Applications
  • Keywords: HDK N20
  • Published: 2026-11-20 01:11:37
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Immunotherapy is a therapeutic approach implemented using the immune system of biological organisms, and can be carried out by activating or suppressing the immune system. 438, 439 The most common application is cancer immunotherapy. 440, 441 In cancer therapy, immunotherapeutic agents such as tumor-associated antigens or immune adjuvants are often used to educate antigen-presenting cells and T cells, thus to enhance the host immune response to cancer. However, it remains a difficulty to improve the delivery efficiency of immunotherapeutic agents, to steer clear of dose-dependent toxicity, and to mitigate immune-mediated adverse impacts. 438, 439 In this regard, MSNs have emerged as a perfect multifunctional platform for improving immunotherapy because of their excellent porosity, good biocompatibility and ease of surface modification. 30, 31 In MSNs-based immunotherapy, MSNs can play a role in different periods of the cancer immune cycle. 31 For example, chemokine-loaded MSNs promote T-cell tumor chemotaxis, 442 MSNs-based platforms regulate the immune checkpoint proteins, 443 MSNs loaded with chemotherapeutic drugs, 444 photosensitizers, 445 sonosensitizers 446 or PTAs 447 induce immunogenic cell death (ICD), and MSNs as vaccine vehicles are employed to deliver antigens and adjuvants. In particular, MSNs themselves can serve as effective adjuvants, and contribute to the recruitment and activation of immune cells. 448, 449, 450 At present, there has been considerable progress in MSNs-based immunotherapy platforms. A few recent studies are presented as brief instances. Large-pore MSNs-coated upconversion NPs are used as immune adjuvants to deliver photosensitizers merocyanine 540, model proteins, and tumor antigens for synergistic photodynamic immunotherapy of cancer. 122 The diselenide-bridged organic MSNs loaded with chemotherapeutic ruthenium compound were acted as potential ICD nanoamplifiers for improved cancer chemo-immunotherapy. 451 Au, BP co-loaded MSNs modified with macrophage cell membrane were applied to deliver CO precursor for enhancing SDT-induced ICD impact and inhibiting the expansion and metastasis of breast tumor. 446

What Is Silica? A Simple Explanation of Silica, Its Forms and Uses

Respirable Crystalline Silica OSHA Standard: Exposure Limits and Compliance Requirements
Wang, Y. et al. MRI‐visualized, dual‐targeting, combined tumor therapy using magnetic graphene‐based mesoporous silica. Small 10, 109-116 (2014). Article CAS PubMed Google Scholar
How to Disperse Fumed Silica: Methods, Equipment and Common Mistakes
Zhou, M. et al. Cancer cell membrane camouflaged semi‐yolk@spiky‐shell nanomotor for enhanced cell adhesion and synergistic therapy. Tiny 16, 2003834 (2020). Article CAS Google Scholar
What Is Silica Slurry? Composition, Types and Uses in Polishing
Thermal Conductive Filler: Silica vs Alumina vs Boron Nitride Compared

Silica for Floor Coatings: Anti-Slip, Matting and Rheology Functions

What is silica (SiO₂)?

silica MSDS

What is the difference between fumed silica and precipitated silica?

spherical silica market

What drives silica raw material prices?

fumed silica market Cai, X. et al. Integrating in situ formation of nanozymes with three-dimensional dendritic mesoporous silica nanospheres for hypoxia-overcoming photodynamic therapy. Nanoscale 10, 22937-22945 (2018). Post CAS PubMed Google Scholar

Cite this article: Silica Raw Materials News. "INS 551 Explained: Silicon Dioxide Food Additive Code, Uses and Regulations ." Published 2026-11-20 01:11:37. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.